Deknatel launches heart instruments range:
This article was originally published in Clinica
Executive Summary
Deknatel Snowden Pencer launched a range of instruments for minimally invasive coronary bypass grafting at the American Association of Thoracic Surgeons meeting. The instruments for internal mammary artery procedures include forceps, scissors, needle holders, rib spreaders and a three-chip camera. Deknatel, which is based in Tucker, Georgia, is being purchased by Genzyme (see Clinica No 708, p 13).
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.